Literature DB >> 24923734

Cell proliferation and modulation of interaction of estrogen receptors with coregulators induced by ERα and ERβ agonists.

Nynke M Evers1, Johannes H J van den Berg2, Si Wang2, Diana Melchers3, René Houtman3, Laura H J de Haan2, Antwan G H Ederveen4, John P Groten5, Ivonne M C M Rietjens2.   

Abstract

The aim of the present study was to investigate modulation of the interaction of the ERα and ERβ with coregulators in the ligand responses induced by estrogenic compounds. To this end, selective ERα and ERβ agonists were characterized for intrinsic relative potency reflected by EC50 and maximal efficacy towards ERα and ERβ mediated response in ER selective reporter gene assays, and subsequently tested for induction of cell proliferation in T47D-ERβ cells with variable ERα/ERβ ratio, and finally for ligand dependent modulation of the interaction of ERα and ERβ with coregulators using the MARCoNI assay, with 154 unique nuclear receptor coregulator peptides derived from 66 different coregulators. Results obtained reveal an important influence of the ERα/ERβ ratio and receptor selectivity of the compounds tested on induction of cell proliferation. ERα agonists activate cell proliferation whereas ERβ suppresses ERα mediated cell proliferation. The responses in the MARCoNI assay reveal that upon ERα or ERβ activation by a specific agonist, the modulation of the interaction of the ERs with coregulators is very similar indicating only a limited number of differences upon ERα or ERβ activation by a specific ligand. Differences in the modulation of the interaction of the ERs with coregulators between the different agonists were more pronounced. Based on ligand dependent differences in the modulation of the interaction of the ERs with coregulators, the MARCoNI assay was shown to be able to classify the ER agonists discriminating between different agonists for the same receptor, a characteristic not defined by the ER selective reporter gene or proliferation assays. It is concluded that the ultimate effect of the model compounds on proliferation of estrogen responsive cells depends on the intrinsic relative potency of the agonist towards ERα and ERβ and the cellular ERα/ERβ ratio whereas differences in the modulation of the interaction of the ERα and ERβ with coregulators contribute to the ligand dependent responses induced by estrogenic compounds.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell proliferation; Coregulators; ERA-45; ERB-041; ERα; ERβ; Estradiol; Genistein

Mesh:

Substances:

Year:  2014        PMID: 24923734     DOI: 10.1016/j.jsbmb.2014.06.002

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  8 in total

1.  Development of a recombinant human ovarian (BG1) cell line containing estrogen receptor α and β for improved detection of estrogenic/antiestrogenic chemicals.

Authors:  Jennifer C Brennan; Arzoo Bassal; Guochun He; Michael S Denison
Journal:  Environ Toxicol Chem       Date:  2015-12-09       Impact factor: 3.742

2.  ERβ modulates genistein's cisplatin-enhancing activities in breast cancer MDA-MB-231 cells via P53-independent pathway.

Authors:  Ren Liu; Xiaolin Xu; Chenglin Liang; Xin Chen; Xiaowei Yu; Hongfei Zhong; Wenxiu Xu; Yu Cheng; Wei Wang; Yudong Wu; Lehan Yu; Xiaojuan Hu
Journal:  Mol Cell Biochem       Date:  2019-02-08       Impact factor: 3.396

3.  Prediction of selective estrogen receptor beta agonist using open data and machine learning approach.

Authors:  Ai-Qin Niu; Liang-Jun Xie; Hui Wang; Bing Zhu; Sheng-Qi Wang
Journal:  Drug Des Devel Ther       Date:  2016-07-18       Impact factor: 4.162

4.  Estrogen accelerates the resolution of inflammation in macrophagic cells.

Authors:  Alessandro Villa; Nicoletta Rizzi; Elisabetta Vegeto; Paolo Ciana; Adriana Maggi
Journal:  Sci Rep       Date:  2015-10-19       Impact factor: 4.379

Review 5.  The potential health effects of dietary phytoestrogens.

Authors:  Ivonne M C M Rietjens; Jochem Louisse; Karsten Beekmann
Journal:  Br J Pharmacol       Date:  2016-10-20       Impact factor: 8.739

6.  Evaluation of the possibility of selective modulation of retinal glucose transporters in diabetic complications: An experimental study.

Authors:  Kanuj Mishra; Madhu Nath; Nabanita Halder; Thirumurthy Velpandian
Journal:  Indian J Pharmacol       Date:  2020 Nov-Dec       Impact factor: 1.200

Review 7.  Posttranslational Modifications of Smurfs: Emerging Regulation in Cancer.

Authors:  Longtao Yang; Wenwen Zhou; Hui Lin
Journal:  Front Oncol       Date:  2021-02-22       Impact factor: 6.244

Review 8.  The Potential Role of Nutraceuticals as an Adjuvant in Breast Cancer Patients to Prevent Hair Loss Induced by Endocrine Therapy.

Authors:  Giorgio Dell'Acqua; Aleksander Richards; M Julie Thornton
Journal:  Nutrients       Date:  2020-11-18       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.